Disease Markers / 2015 / Article / Tab 1

Research Article

Assessment of Immunological Biomarkers in the First Year after Heart Transplantation

Table 1

Overview about demographic data and transplantation history. Data are presented for the whole study population (row 2) and according to the appearance of rejection within the first year after HTx (rows 3 and 4).

Whole populationPatients without rejection in the first year after HTxPatients with rejection within the first 3 months after HTx

46376
Age at HTx (±SD)50.6 ± 12.5 yrs50.5 ± 12.8 yrs48.3 ± 11.3 yrs
Female gender (%) (28%) (35%) (17%)
Disease leading to HTx
 DCM
 ICM
 Other
Assist device support before HTx
Re-HTx
Death within the first year after HTx
Panel reactive antigen before HTx
 PRA = 0
 PRA > 0, <20
 PRA ≥ 20
Transplant rejection (histopathological EMB grade ≤  grade IB or higher)
 1st quarter6
 2nd quarter
 2nd half year

DCM, dilated cardiomyopathy; EMB, endomyocardial biopsy; HTx, heart transplantation; ICM, ischemic cardiomyopathy; PRA, panel reactive antibody; Re-HTx, repeat heart transplantation; SD, standard deviation.